Godrej Industries (500164) Q1 26/27 earnings summary

Executive summary

• Consolidated total income for Q1 FY27 rose to ₹6,360 crore, but net profit declined 19% to ₹284 crore, reflecting margin pressures despite revenue growth.

• Unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, were approved, with statutory auditors issuing an unmodified review conclusion.

• The quarter marked a leadership transition, with Pirojsha Godrej appointed as Executive Chairperson effective August 14, 2026.

• Key subsidiaries and associates contributed significantly, with strong performance in chemicals, consumer products, and real estate, but some segments faced profit declines.

Financial highlights

• Total income increased to ₹6,360 crore from ₹5,719 crore year-over-year.

• Consolidated revenue from operations for Q1 FY27 was ₹5,448.09 crore, up from ₹4,459.80 crore in Q1 FY26.

• Net profit (including associates) decreased 19% to ₹284 crore.

• Consolidated net profit after tax stood at ₹523.36 crore, compared to ₹725.35 crore in Q1 FY26.

• Interest expenses rose to ₹745 crore from ₹576 crore.

Segment performance

• Chemicals revenue grew 31% to ₹1,161 crore; PBIT up 86% to ₹159 crore.

• Consumer products sales up 19% YoY, net profit up 11%; strong growth in Home Care and Personal Care.

• Real estate income fell to ₹1,337 crore (from ₹1,593 crore), net profit down to ₹350 crore (from ₹600 crore); booking value up 22% YoY.

• Agrovet revenue rose to ₹2,870 crore (from ₹2,626 crore); net profit declined to ₹135 crore (from ₹161 crore).

• Animal Nutrition and Dairy segments showed robust topline and volume growth.